AR034222A1 - Una composicion farmaceutica en base a una combinacion de un taxano con una quinasa ciclina-dependiente - Google Patents

Una composicion farmaceutica en base a una combinacion de un taxano con una quinasa ciclina-dependiente

Info

Publication number
AR034222A1
AR034222A1 ARP020101061A ARP020101061A AR034222A1 AR 034222 A1 AR034222 A1 AR 034222A1 AR P020101061 A ARP020101061 A AR P020101061A AR P020101061 A ARP020101061 A AR P020101061A AR 034222 A1 AR034222 A1 AR 034222A1
Authority
AR
Argentina
Prior art keywords
dependent kinase
pharmaceutical composition
taxan
cycline
combination
Prior art date
Application number
ARP020101061A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR034222A1 publication Critical patent/AR034222A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe una composición farmacéutica que comprende Taxol(r), Taxotere(r) o derivados de los mismos, y una quinasa ciclina-dependiente, y también se refiere a una forma de administración en la cual el taxano es administrado de manera intermitente y la quinasa ciclina-dependiente es administrada repetidamente dentro del mismo ciclo.
ARP020101061A 2001-03-23 2002-03-22 Una composicion farmaceutica en base a una combinacion de un taxano con una quinasa ciclina-dependiente AR034222A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04

Publications (1)

Publication Number Publication Date
AR034222A1 true AR034222A1 (es) 2004-02-04

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101061A AR034222A1 (es) 2001-03-23 2002-03-22 Una composicion farmaceutica en base a una combinacion de un taxano con una quinasa ciclina-dependiente

Country Status (33)

Country Link
US (2) US20020182204A1 (es)
EP (1) EP1372652B1 (es)
JP (1) JP2004521140A (es)
KR (1) KR100879712B1 (es)
CN (1) CN1498107A (es)
AR (1) AR034222A1 (es)
AT (1) ATE395917T1 (es)
AU (1) AU2002312815B2 (es)
BR (1) BR0208221A (es)
CA (1) CA2441441C (es)
CY (1) CY1110449T1 (es)
CZ (1) CZ301423B6 (es)
DE (1) DE60226710D1 (es)
DK (1) DK1372652T3 (es)
EA (1) EA007815B1 (es)
ES (1) ES2305253T3 (es)
HR (1) HRPK20030766B3 (es)
HU (1) HU229258B1 (es)
IL (2) IL158058A0 (es)
ME (1) MEP16408A (es)
MX (1) MXPA03007743A (es)
NO (1) NO332441B1 (es)
NZ (1) NZ527655A (es)
PE (1) PE20020907A1 (es)
PL (1) PL206118B1 (es)
PT (1) PT1372652E (es)
RS (1) RS50681B (es)
SI (1) SI1372652T1 (es)
SK (1) SK287481B6 (es)
TW (1) TWI355935B (es)
UY (1) UY27220A1 (es)
WO (1) WO2002076484A2 (es)
ZA (1) ZA200307381B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003217982A1 (en) * 2002-03-06 2003-09-22 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
BR0316010A (pt) * 2002-11-06 2005-09-13 Cyclacel Ltd Combinação
BRPI0707580A2 (pt) * 2006-02-10 2011-05-10 Nerviano Medical Sciences Srl combinaÇÕes compreendendo um inibidor cdk e um anticorpo do fator de crescimento ou antimitàtico
MX2013005661A (es) * 2010-11-19 2013-09-13 Piramal Entpr Ltd Combinacion farmaceutica de paclitaxel y un inhibidor cdk (quinasa dependiente de ciclina).
SG193505A1 (en) * 2011-04-01 2013-10-30 Astrazeneca Ab Therapeutic treatment
AU2012321110B2 (en) 2011-11-30 2014-10-23 Astrazeneca Ab Combination treatment
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
AU2195297A (en) * 1996-02-20 1997-09-02 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers

Also Published As

Publication number Publication date
PL367702A1 (en) 2005-03-07
US20020182204A1 (en) 2002-12-05
SK287481B6 (sk) 2010-11-08
HUP0303589A3 (en) 2007-05-02
AU2002312815B2 (en) 2006-08-24
PL206118B1 (pl) 2010-07-30
MXPA03007743A (es) 2004-11-12
TWI355935B (en) 2012-01-11
CY1110449T1 (el) 2015-04-29
DE60226710D1 (de) 2008-07-03
HU229258B1 (en) 2013-10-28
ATE395917T1 (de) 2008-06-15
YU69503A (sh) 2006-08-17
HUP0303589A2 (hu) 2004-03-01
IL158058A (en) 2010-02-17
NO20034124L (no) 2003-09-16
EP1372652B1 (en) 2008-05-21
CA2441441C (en) 2009-05-26
HRPK20030766B3 (en) 2006-11-30
DK1372652T3 (da) 2008-09-22
PT1372652E (pt) 2008-07-24
SK11692003A3 (sk) 2004-03-02
BR0208221A (pt) 2004-03-02
EA007815B1 (ru) 2007-02-27
CZ20032551A3 (en) 2004-07-14
KR100879712B1 (ko) 2009-01-22
KR20030086318A (ko) 2003-11-07
EP1372652A2 (en) 2004-01-02
NO20034124D0 (no) 2003-09-16
NO332441B1 (no) 2012-09-17
US20060128640A1 (en) 2006-06-15
UY27220A1 (es) 2002-09-30
NZ527655A (en) 2006-03-31
SI1372652T1 (sl) 2008-10-31
CN1498107A (zh) 2004-05-19
ES2305253T3 (es) 2008-11-01
IL158058A0 (en) 2004-03-28
CZ301423B6 (cs) 2010-02-24
RS50681B (sr) 2010-06-30
HRP20030766A2 (en) 2005-06-30
CA2441441A1 (en) 2002-10-03
WO2002076484A2 (en) 2002-10-03
ZA200307381B (en) 2005-03-30
JP2004521140A (ja) 2004-07-15
WO2002076484A3 (en) 2003-01-03
EA200301053A1 (ru) 2004-02-26
PE20020907A1 (es) 2002-12-19
MEP16408A (en) 2010-10-10

Similar Documents

Publication Publication Date Title
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
AR109263A2 (es) Composición que comprende moxidectina
EA200300323A1 (ru) ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ)
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
DE602004010493D1 (de) Kaugummi in der form von mehrschichttabletten
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
CY1110170T1 (el) Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης
CY1110449T1 (el) Συνδυασμος δοκεταξελης και φλαβοπιριδinολης
DE60143363D1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
UY27018A1 (es) Derivados de la pirimidina
AR022588A1 (es) Derivados de mevinolina
EA200200313A1 (ru) Применение доцетаксела для лечения печеночно-клеточного рака
AR039232A1 (es) Una formulacion farmaceutica que comprende al menos un compuesto seleccionado del grupo formado por hipnoticos no barbituricos y no benzodiacepinicos, y melatonina
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
BR0014687A (pt) Compostos de taxano pentacìclico
SV2006002224A (es) Composicion farmaceutica ref. bhco41368-sv
UY26176A1 (es) Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas.
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
EA200601632A1 (ru) Новая комбинация гетероциклического соединения и антиоксиданта и фармацевтические композиции, которые её содержат
AR062375A1 (es) Cristal de epotilona b y composiciones farmaceuticas
CL2010000166A1 (es) Uso de gaboxadol para preparar una composicion farmaceutica para ser utilizada en combinacion con un inhibidor de la reabsorcion de serotonina o con cualquier otro compuesto que logre una elevacion en el nivel de serotonina extracelular; y composicion farmaceutica (sol. div. 1607-04).
PA8555301A1 (es) Preparacion de inhibidores de la proteasa del vih

Legal Events

Date Code Title Description
FB Suspension of granting procedure